Mouse Models of Myeloid Malignancies
Faisal Basheer1,2,3, George Vassiliou1,2,3
1Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Department of Haematology, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Cold Spring Harbor Perspectives in Medicine
|February 20, 2020
Summary
Mouse models are crucial for studying myeloid malignancies, including clonal hematopoiesis, myelodysplastic syndromes, and acute myeloid leukemia. Advances in gene editing, like CRISPR-Cas9, enhance the development and utility of these models for disease research.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Mouse models are essential for investigating human myeloid malignancies.
- These models recapitulate disease progression, microenvironment interactions, and treatment effects.
- Gene-editing technologies, such as CRISPR-Cas9, have revolutionized the creation of genetically modified mouse models.
Purpose of the Study:
- To provide an overview of key mouse models in myeloid leukemogenesis research.
- To highlight models relevant to clonal hematopoiesis, myelodysplastic syndromes, and normal karyotype acute myeloid leukemia.
- To emphasize the role of these models in understanding disease mechanisms and potential therapies.
Main Methods:
- Review of existing literature on mouse models for myeloid malignancies.
- Focus on models applicable to specific myeloid disease subtypes.
- Discussion of gene-editing technologies in model development.
Main Results:
- Identified several critical mouse models advancing myeloid leukemogenesis research.
- Demonstrated the utility of these models in studying disease initiation, progression, and therapeutic response.
- Highlighted the impact of CRISPR-Cas9 on accelerating model generation and modification.
Conclusions:
- Mouse models are indispensable tools for dissecting the complexities of myeloid malignancies.
- Current models, enhanced by gene editing, offer powerful platforms for preclinical research.
- Further development and application of these models will accelerate discoveries in clonal hematopoiesis, MDS, and AML.
